The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: LFTs, Liver Function Tests, Liver Panel
Also known as: Anti HCV, HCV Antibody
The Hepatitis C Antibody & Liver Function Panel panel contains 2 tests with 12 biomarkers.
Brief Description: The Hepatitis C Antibody & Liver Function Panel is a comprehensive diagnostic tool used to detect the presence of hepatitis C virus (HCV) antibodies and assess liver function. This panel includes the Hepatitis C Antibody with Reflex to Quantitative HCV RNA PCR test, along with a series of liver function tests: Albumin, Albumin/Globulin Ratio, Alkaline Phosphatase, Alanine Transaminase (ALT), Aspartate Aminotransferase (AST), Bilirubin Direct, Bilirubin Indirect, Bilirubin Total, Globulin, and Protein Total. This panel is crucial for diagnosing HCV infection and evaluating the liver's health and functionality.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
The Hepatitis C Antibody & Liver Function Panel is often ordered when a patient has symptoms indicative of liver disease, such as jaundice, fatigue, or abdominal pain, or has risk factors for hepatitis C infection, such as a history of intravenous drug use, blood transfusions before 1992, or exposure to HCV. It's also used to monitor the liver health of patients known to be infected with HCV or undergoing treatment for hepatitis C.
Hepatitis C Antibody with Reflex to Quantitative HCV RNA PCR: Detects antibodies to the hepatitis C virus as an initial screen. If positive, the test reflexes to a quantitative PCR to measure the viral load, confirming active infection.
Albumin: Measures the level of albumin in the blood, a protein made by the liver, indicating the liver's synthetic function.
Albumin/Globulin Ratio: Compares the amounts of albumin and globulins in the blood, providing insight into liver function and the body's immune response.
Alkaline Phosphatase (ALP): Elevated levels can indicate liver damage or disease, particularly in the bile ducts.
Alanine Transaminase (ALT) and Aspartate Aminotransferase (AST): Enzymes found in the liver that, when elevated, indicate liver cell injury.
Bilirubin Direct, Bilirubin Indirect, and Bilirubin Total: Measure different forms of bilirubin in the blood, with abnormalities suggesting liver dysfunction or bile duct obstruction.
Globulin: Part of the immune system, globulin levels can indicate liver health and immune status.
Protein Total: Measures the total amount of albumin and globulin in the blood, providing a general status of nutritional health and liver function.
This panel is instrumental in diagnosing and managing conditions such as:
Hepatitis C Infection: Confirmed by the presence of HCV antibodies and a detectable viral load, indicating an active or past infection.
Liver Cirrhosis: Characterized by abnormal liver function tests, particularly albumin and bilirubin levels, suggesting advanced liver disease.
Hepatic Inflammation: Indicated by elevated ALT and AST levels, which can result from HCV infection or other liver insults.
Bile Duct Obstruction: Suggested by elevated levels of direct bilirubin and ALP, pointing to issues with bile flow.
Healthcare professionals utilize this panel to:
Guide Hepatitis C Treatment: Confirming HCV infection and assessing liver damage is crucial for determining treatment options and monitoring the effectiveness of antiviral therapy.
Manage Liver Disease: Abnormal liver function test results can lead to further diagnostic testing, lifestyle modifications, or medical interventions to manage liver health.
Monitor Disease Progression: Regular testing can track the progression of liver disease in patients with chronic HCV infection, guiding adjustments in treatment and management strategies.
The Hepatitis C Antibody & Liver Function Panel is a vital tool in diagnosing hepatitis C infection and assessing liver health. By providing a comprehensive overview of liver function and the presence of HCV, this panel enables healthcare providers to diagnose, treat, and monitor patients effectively, improving outcomes for those with hepatitis C and related liver conditions.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.